Search clinical trials for: Carfilzomib 56 MG [Kyprolis]
Total 144 results
-
Thomas LundRecruiting
-
Washington University School of MedicineCompleted
-
AmgenMultiple Myeloma Research FoundationApproved for marketing
-
AmgenCompletedEnd-stage Renal Disease | Relapsed Multiple MyelomaUnited States, Australia, Canada
-
University of NebraskaNational Cancer Institute (NCI); AmgenCompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Recurrent Adult T-cell Leukemia/LymphomaUnited States
-
AmgenCompleted
-
AmgenCompletedMultiple MyelomaUnited States, Canada
-
AmgenCompletedRenal Insufficiency | Multiple MyelomaUnited States
-
SCRI Development Innovations, LLCAmgenCompletedNeuroendocrine CancerUnited States
-
John F. McDyer, MDCompletedLung Transplant RejectionUnited States
-
AmgenCompletedMultiple Myeloma | Solid TumorsUnited States, Canada
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
Spectrum Health HospitalsCompletedMultiple MyelomaUnited States
-
Samsung Medical CenterRecruiting
-
iOMEDICO AGAmgenActive, not recruiting
-
University of BirminghamCelgene; Amgen; BloodwiseCompletedPeripheral T Cell LymphomaUnited Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Stichting European Myeloma NetworkFondazione EMN Italy OnlusCompletedMultiple MyelomaGermany, Italy
-
PfizerRecruiting
-
Janssen Research & Development, LLCCompletedTreatment Resistant Depressive DisorderUnited States, Japan, Belgium
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Janssen Research & Development, LLCCompletedDepressive Disorder, Treatment-ResistantUnited States
-
Janssen Pharmaceutical K.K.Completed
-
Northwestern UniversityAmgenTerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary Syndrome | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IA Mycosis Fungoides/Sezary Syndrome | Stage... and other conditionsUnited States
-
Cancer Research and Biostatistics Clinical Trials...Washington University School of Medicine; Lucille P. Markey Cancer Center at...CompletedSmall Cell Lung Carcinoma | Non Small Cell Lung Carcinoma | Irinotecan Sensitive CancersUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Non-Secretory Plasma Cell Myeloma | PlasmacytosisUnited States
-
University of Michigan Rogel Cancer CenterCompletedHematologic Malignancies | Graft-Versus-Host Disease | RelapseUnited States
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
E. Steve WoodleAmgenUnknown
-
AmgenCompletedExtensive-Stage Small-Cell Lung CancerCanada, United States, Russian Federation
-
Duke UniversityBristol-Myers SquibbWithdrawnLung Transplant Rejection | Antibody-mediated Rejection
-
Janssen-Cilag International NVCompletedDepressive Disorder, MajorIsrael, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; PPD; Rho Federal Systems Division, Inc.; Immune Tolerance...RecruitingHighly Sensitized Prospective Kidney Transplant RecipientsUnited States
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
AmgenOnyx Therapeutics, Inc.CompletedRelapsed and Refractory Multiple MyelomaChina
-
AmgenCompletedLymphoma | Small Cell Lung Cancer | Multiple Myeloma | Ovarian Cancer | Non-small Cell Lung Cancer | Solid Tumors | Renal CancerUnited States
-
AmgenCompletedMultiple MyelomaUnited States
-
University of ChicagoActive, not recruitingMultiple MyelomaUnited States, Poland
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Emory UniversityOnyx Therapeutics, Inc.TerminatedMultiple MyelomaUnited States
-
Loyola UniversityAmgenRecruiting
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
Wake Forest University Health SciencesIncyte Corporation; Amgen; Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
AmgenCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma | Waldenstrom's Macroglobulinemia | Hodgkin's DiseaseUnited States
-
University of ChicagoJanssen Scientific Affairs, LLC; AmgenRecruitingMultiple Myeloma | MyelomaUnited States
-
University of ChicagoRecruiting
-
AbbVieGenentech, Inc; Onyx Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States, Australia, Hungary, Puerto Rico, Spain
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States